Sarah Gheuens Agios Pharmaceuticals, Inc. (AGIO) insider trading activity

AGIO Quotes by TradingView

Sarah Gheuens is Chief Medical Officer of AGIOS PHARMACEUTICALS, INC.. Currently has a direct ownership of 53,897 shares of AGIO, which is worth approximately $1.6 Million. The most recent transaction as insider was on Feb 10, 2022, when has been sold 2,162 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.9K
23.23% 3M change
37.96% 12M change
Total Value Held $1.6 Million

Sarah Gheuens Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 10 2022
BUY
Exercise of conversion of derivative security
-
2,162 Added 25.82%
6,210 Common Stock
Dec 02 2021
SELL
Payment of exercise price or tax liability
$8,680 $35.0 p/Share
248 Reduced 5.77%
4,048 Common Stock
Dec 02 2021
BUY
Exercise of conversion of derivative security
-
834 Added 16.26%
4,296 Common Stock

Also insider at

VRDN
Viridian Therapeutics, Inc.\DE Healthcare
SG

Sarah Gheuens

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on AGIO

Follow AGIOS PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGIO shares.

Notify only if

Insider Trading

Get notified when an Agios Pharmaceuticals, Inc. insider buys or sells AGIO shares.

Notify only if

News

Receive news related to AGIOS PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGIO